Live Online Training: Lab Data Integrity - A Practical Approach for Generating and Auditing Laboratory Records

Live Online Training: Lab Data Integrity - A Practical Approach for Generating and Auditing Laboratory Records

Course No 19030

This course is part of the GMP Certification Programme "ECA Certified Data Integrity Manager". Learn more.

All times mentioned are CEST.

Costs

ECA-Member*: EUR 2380,--
Non ECA Member*: EUR 2580,--
EU/GMP Inspectorates*: EUR 1290,--
APIC Member Discount*: EUR 2480,--

(All prices excl. VAT)

* payable by credit card American Express Visa Mastercard

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org

Speakers

Dr Christopher Burgess, Chairman of the ECA Analytical Quality Control Working Group
Dr Bob McDowall, Member of the ECA IT Compliance Interest Group

Objectives

The learning objectives are firstly, understand the data integrity requirements of a GMP regulated laboratory in Pharmaceutical organisations and contract labs and secondly, how laboratory personnel can ensure compliance and be able to defend their positions. Records generated by three processes will be taken through the presentations and workshops: paper only with records maintained in a laboratory notebook or controlled sheets, hybrid system with signed paper records with underlying electronic records and an electronic system using electronic signatures. Second person review is a critical process that needs to be thorough and effective to ensure that data issues are picked up and resolved.

The auditing part of the Live Online Training will develop the understanding of what is required for a data integrity on-site or remote audit of a laboratory computerized system and then develop the principles, based mainly on workshops and Q&A session, of how to audit hybrid and electronic laboratory systems. The scope of auditing (on-site and remote) a system for data integrity will be developed during the training along with a risk based prioritisation of the key areas to focus audit attention on. In preparation for the final sessions there will be workshops dealing with specific data integrity topics.

Background

Data Integrity is currently the major concern with both the FDA and European Regulatory Agencies. Many FDA warning letters and EU GMP inspections have highlighted major data integrity failures at companies globally. The regulatory concern has been responded by the FDA issuing Compliance Program Guide (CPG) 7346.832 that covers Pre-Approval Inspections. This document became effective in May 2012 after Agency inspectors received training in Data Integrity where they focus on computer systems and not the paper output. The CPG objective 3 covers the laboratory data integrity audit. In April 2016 a draft Data Integrity guidance was issued for industry comment.

In March 2015, also MHRA issued an updated Data Integrity Guidance containing an expansion of the expectations of Data Integrity governance together with a list of 19 definitions and expectations for each one. Followed in July 2016 by a more general guidance for GXP data integrity.

In June 2016, the World Health Organisation issued a final version of a guidance document which provides a more encompassing explanation of Data Integrity and also data governance expectations for regulated healthcare companies. EMA and PIC/S both issued draft Data Integrity guidance documents in August 2016. ECA have published two versions of Data Governance and Data Integrity guidance in 2016 and 2018. The GAMP Forum has  published a Guide on Records and Data Integrity in 2017 and the first of three Good Practice Guides on Data Integrity - Key Concepts. Lastly, PDA has also issued a guidance document for pharmaceutical laboratories in August 2018.

The emphasis of all regulators is on the ALCOA principles to outline regulatory expectations for ways to ensure the integrity of data over the life cycle.
The Live Online Training focuses on three types of records that can be found in analytical laboratories working to GMP: paper, hybrid computerized system and electronic workflows with electronic signatures. Through presentations, workshops and Q&A sessions attendees are taken through the process from analysis to generation of results to understand Data Integrity issues.

Target Group

This Live Online Training will be of significant value to:
  •  Managers and scientists from Quality Control and Analytical Development Laboratories wanting to understand the Data Integrity and audit process
  •  Quality Assurance personnel
  •  Contract Research Organisation and Contract Manufacturing Organisation laboratory and QA personnel
  •  Auditors (internal and external) responsible for assessing laboratory quality and Data Integrity

Technical Requirements

For our Live Online Training Courses and Webinars, we use Cisco WebEx, one of the leading suppliers of online meetings.

At http://www.webex.com/test-meeting.html you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in.  Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.

Programme

GMP Regulations Impacting Laboratory Data and Results
  • EU GMP requirements
  • MHRA and WHO Data Integrity Guidances
  • FDA GMP requirements
  • FDA Guidance documents OOS, Inspection of QC labs
  • Inspection findings 483 and warning letters
  • Defining Data Integrity, “complete data” and „raw data“
Principles for the Generation of Data
  • Observational tests and instrument tests
  • Training of staff
  • Qualified analytical instruments and validated Software
  • Integrity issues
  • Application of ALCOA+ principles
WORKSHOP I: Generation of Data
  • What are the requirements for raw data integrity?
  • Three scenarios covering
    • a paper System
    • a hybrid system
    • a client server electronic system
Processing and Reporting of Data
  • Paper / hybrid based Systems
  • Networked systems with electronic records and signatures
  • Calculations and transformation of data manually and by computer applications
  • Application of ALCOA+ principles to the process
  • Calculating the reportable value and comparison with the specification
  • Paper processes versus electronic processes
  • Linkage with out of specification investigations (OOS)
WORKSHOP II: Processing and Reporting of Data
  • Reviewing an analytical record
  • Scenario covering paper based record and an electronic system
Reviewing Data
  • Role of the second person review
  • Determination that the reportable result is correctly calculated
WORKSHOP III: Data Review – Paper Records
 Application of ALCOA+ principles for the review of paper records

Collation and Reporting Results
  • Role of the second person Review
  • Determination that the reportable result is correctly calculated
  • Identification and correction of errors for paper and electronic systems
  • Do you have complete data?
WORKSHOP IV: Paper, Hybrid and Electronic Reporting Processes
  • Discussion of the strengths and weaknesses of reporting processes
Data Integrity Self Inspections and On-site and Remote Audits for Hybrid and Electronic Systems
  •  Observations and findings
  •  Remote audits: practicalities, limitations and problems
WORKSHOP V: Electronic Signature Auditing
  • Use of electronic signatures can mask some Data Integrity issues
  • Can the attendees find what those issues are?
  • Feedback from the teaching team
WORKSHOP VI: Risk Assessment and Prioritisation
  • So much to do but so little time – risk management in practice
  • When conducting a Data Integrity audit which areas within a pharmaceutical quality system will be the focus?
  • Feedback from the teaching team
WORKSHOP VII: Audit of an Excel Spreadsheet
  • Attendees will be given an example of a spreadsheet
  • What questions need to be asked to determine if there is sufficient Data Integrity and control?
  • Feedback from the teaching team
WORKSHOP VIII: Auditing a Hybrid Standalone System
  • A laboratory system is used in hybrid mode
  • What questions should the auditor ask to determine if there are any data integrity problems?
  • Feedback and discussion with the teaching team
WORKSHOP IX: Auditing a Networked Laboratory System – Audit Trail Review
  • Review of audit trail entries is a key data integrity requirement of Annex 11
  • Attendees will review the printout of an audit trail to determine if there any data integrity issues to be raised?
  • Can the attendees find what those issues are?
  • Feedback and discussion with the teaching team
WORKSHOP X: Preparing for the Data Integrity Audit
  • Preparation for a remote audit - what can you read?
  • Requesting the Site Master File
  • Requesting documents
  • Handling time zone differences
  • What video conferencing system will you use?
WORKSHOP XI: Conducting a Remote Data Integrity Audit
  • Remote laboratory tour - what are you allowed to see?
  • On-line access to networked computer Systems
  • Access to standalone systems?
  • Viewing documents on-line
  • Screens for the remote audit and taking notes
WORKSHOP XII: Reviewing the Follow up Responses from a Remote Data Integrity Audit
  • Access to documents after the Audit
  • Reviewing responses to audit findings
  • Resolution of audit findings with evidence
Review of the Course and Key Learning Points

Go back

GMP Conferences by Topics